Tailin Biotech announced that the company previously reviewed and passed a bill to terminate the issuance of convertible corporate bonds to unspecified targets and withdraw application documents, and the company and sponsor Great Wall Securities have submitted a withdrawal application to the Shenzhen Stock Exchange. On August 21, 2026, the company received a decision from the Shenzhen Stock Exchange to terminate the review of the company's application to issue convertible corporate bonds to unspecified targets. The Shenzhen Stock Exchange decided to terminate this issuance review in accordance with relevant rules.

Tailin Biotech announced that the company previously reviewed and passed a bill to terminate the issuance of convertible corporate bonds to unspecified targets and withdraw application documents, and the company and sponsor Great Wall Securities have submitted a withdrawal application to the Shenzhen Stock Exchange. On August 21, 2026, the company received a decision from the Shenzhen Stock Exchange to terminate the review of the company's application to issue convertible corporate bonds to unspecified targets. The Shenzhen Stock Exchange decided to terminate this issuance review in accordance with relevant rules.